Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-intensity unrelated umbilical cord blood transplantation for hematological diseases
2004-003845-41Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide and fludarabine in Hematopathy, sponsored by University College London. Primary endpoints: Non-relapse mortality at day 100, Count recovery and 3 more. Started Jan 2009; status: completed.
02
Drugs
cyclophosphamidefludarabine
03
Conditions
Hematopathy
Beyond the preview
Go deeper on 2004-003845-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003845-41.